A new report from the Pistoia Alliance finds that multi-disciplinary innovation, the implementation of new technologies, new approaches to research, the digitisation of R&D and healthcare, and academic contributions to biologics drug R&D are all key trends in the life sciences industry.
The SC Conference brings together the international high performance computing community – a gathering of scientists, engineers, researchers, educators, programmers, system administrators and developers that is unequaled in the world – for an exceptional program of technical presentations, papers, informative tutorials, timely research posters, and Birds of a Feather (BoF) sessions.
DeepMind has announced a new tool in AI research.
Bright Computing and Huawei, a global provider of information and communications technology (ICT) infrastructure and smart devices, announced that the two companies are collaborating to offer intelligent HPC solutions accelerated by ARM and AI technology.
Optibrium, Intellegens and Medicines Discovery Catapult have announced that they have been awarded a £1 million grant from Innovate UK to support the development of artificical Intelligence (AI) in drug discovery
Optibrium, a developer of software for drug discovery, has announced it has signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software
AMAX, an NVIDIA Elite Partner and global provider of AI, Deep Learning and HPC solutions featuring NVIDIA GPUs, announced the integration of the new NVIDIA GeForce RTX cards into its solution line up
Robert Roe reports on developments in AI that are helping to shape the future of high performance computing technology at the International Supercomputing Conference
Spotinst has announced that it has raised $35 million in a Series-B funding round for its AI-based workload management platform, which helps companies to manage and optimise their cloud computing spend across several cloud providers
A partnership between the University of Essex and Provide aims to improve the Uk's National Health Service (NHS) by implementing an AI-powered decision-making engine to determine the service a patient needs
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
